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SUMMARY 
The present report is a study on the side effects experienced by the patients attending the Lithium 
Clinic of the Institute of Psychiatry, Government Rajaji Hospital, Madurai. Out of the 120 (M 78, F42) 
patients studied, 97 had side effects. The effects were examined in respect of their frequency, time of onset 
and course, their relation to tne dose and serum levels oflithium and to the clinical response. The duration 
of therapy ranged from 3 months to 6 years. 
The most frequent side effects were tremors (26.6%) and polyuria (20.8%). 
The side effects occurred at varying peiiods from the onset of therapy. During the first 3 monthi, 
tremors, excess salivation, nausea and abdominal discomfort; weight gain, memory defects and polyuria, 
between 3 months and 1 year; and hypothyroidism, tardive dyskinesia, zxne and hair fall beyond one year. 
Lithium, the most preferred agent in 
prophylaxis of manic depressive psychosis 
lias been an extensively studied drug in 
Psychiatry. It is to mood disorders what 
antibiotics are to infections. Lithium 
exerts numerous effects on the psysiologi-
ca] systems. Some of these are directly or 
indirectly related to its psychotropic action 
and also cause side effects during therapy. 
Side effects, mostly somatic, are quite 
common with lithium as with other psy-
chotropic drugs (NIMH Report, 1970 ; 
Christodoulou etal., 1977; Fieve 1979). 
While some occur early and are transient, 
others appeal later, tending to persist. 
The present communication is a 
report on the side effects experienced by 
the patients 'bserved in the Lilhium 
Clinic of the Madurai Medical College 
and Government Rajaji Hospital, Madu-
rai, India, during the last seven years. 
Earlier publications from this clinic in-
clude studies on clinical response to 
lithium (Venkoba Rao and Harihara-
subramanian, 1978; Venkoba Rao et al., 
1982 (a) and 1982 (b)) on electrolyte 
changes, changes in ECG, changes in 
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renal structure and functions and on 
memory defects (Venkoba Rao etal., 
1979, 1981; Venkoba Rao and Harihara-
subramanian, 1980; Hariharasubra-
manian etal., 1978; Srinivasan etal., 
1978; Sugumar etal., 1980). 
AIM, MATFRIAL AND METHOD 
The present study examines the side 
effects of lithium in respect of their fre-
quency, time of onset and course, their 
relation to the dose and serum levels of 
lithium and to the clinical symptomato-
logy of 120 patients (Male-78, Fcmale-
42) who form the material for the study. 
The side effects noticed in the earlier 
patients in the clinic have been reported 
elsewhere (Venkoba Rao and Harihara-
subromanian 1978; Venkoba Rao et al 
1982a). The age of the patients ranged 
from 21-63 years (Mean : 39.5) (Bipolars-
113, Unipolar manics-3, Unipolar depres-
sives-4). Tl:e oral dose of lithium ranged 
fnm 750-1000 mgm/day and the serum 
lithium, periodically estimated, was in 
the range of 0.6—1.2 mmols/litre. The 
duration of therapy ranged from 3 months 
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to 6 years. The patients received in addi-
tion, phenothiazines and tricyclics occa-
sionally. 
OBSERVATIONS 
The side effects are listed in order of 
frequency of occurrence in Table 1. Of 
the 120 patients, 97 had side effects 
(80.8%) while 23 had no side effects so 
far. More than one spmptom was repor-
ted by 17 (14.2%). The side effects 
relate to neuromuscular and CNS (Tre-
morcs, memory defects, gait, tardive 
dyskinesia), gnstro intestinal (nausea, ab-
dominal discomfort, loose bowels, excess 
salivation), endocrine and metabolic 
systems (hypothyroidism, weight gain), 
water balance (polyuria/polydipsia) and 
skin (acne, fall of hair). 
TABLE I—Frequency of Side Effects. 
No. of patients studied : 120. 
No. of patients in whome side effects 
were observed : 97. 
No. of 
Symptom Cases. 
Tremors 
Polyuria/Polydipsia 
Memory defects .. ... 
Excess salivation .. 
G. I. disturbances 
Weight gain 
Hypothyroidism .. 
Tardive dyskinesia 
Acne 
Fall of hair 
Gait disturbance 
32 
25 
14 
12 
12 
9 
7 
4 
4 
4 
1 
Symptoms such as tremor, salivation 
and G. I. tract disturbances occurred 
early, within the first three months of 
initiation of therapy, whereas memory 
defects, weight gain, polyuria and gait 
disturbances appeared between 3 months 
to one year (Table II). 
TABLE II—Time of appearance of symptoms 
after initiation of therapy. 
Early Intermediate. Late, 
(upto 3 months) (3 months—1 year) (after 1 year). 
Tremor Memory defects. Hypothyroidism. 
Excess salivation- Weight gain. Tardive dyskinesia 
G. I. disturbances Polyuria. Acne. 
Gait disturbance. Fall of hiar. 
Excess salivation, acne, gastrointes-
tinal disturbances and gait problems 
were transient and settled spontaneously. 
Memory deficit, viz., impairment of short 
term recall at 15-second interval, lasted 
longer but became less disturbing as days 
passed. These memory defects have been 
earlier reported by us (Sugumar et al., 
1980). 
Tremors : (N=32) : Fine tremor, 
usually of fingers was the commonest 
symptom, noted quite early during the-
rapy. In seven patients the tremors 
were controlled with 40 mg propranolol 
per day which was discontinued after 2-3 
months and tremors did not recur. In 
others, the magnitude of the tremors 
diminished over time and settled with-
out any measure to counter. Two 
patients developed marked tremulous 
ataxia. Mrs. B. who was free from tre-
mors during a continuous period of 2.5 
years of therapy with lithium and sub-
sequently during a seven month drug-
free period experienced scvcie tremors 
within a week of restarting lithium; the 
serum lithium was 1.6 mMol/litre when 
she had severe tremors. The second 
patient, Mr. M., had tremors within four 
days of starting on lithium for the first 
time. This patient received amitryptiline 
in addition and the serum lithium was A STUDY OF SIDE EFFECTS OF LITHIUM  89 
0.9 mMol/litre. Lithium was withdrawn 
from both of them resulting in cessation 
of tremors. In the first patieni lithium 
was restarted after tremors subsided and 
during the six months of treatment till 
date, tremors have not reippeared. 
Polyuria : (N=25) : Polyuria (24 
hours urine volume : 3.2-4 litres) was 
reported by 25 patients. Renal function 
was investigated in all the patie its and 
did not reveal any gross impairment. 
The polyuria wr.s reversible (Ve.ikoba 
Rao et nl, 1979). Renal biopsy do..e on 
13 of these patients showed nonspecific 
renal changes (Venkobu Rao et nl, 1981). 
Weight gain : (N=9) : Weight 
gain was noted in 9 patients, with an 
average of 4.5 kg. (3-7 kgs). The increase 
was gradual over a period of 2-3 months. 
After the initial increase, however, there 
was a plateau : Over the next few months 
they returned to the pretrea tment level. 
Hypothyroidism : (N=7) : Seven 
patients developed clinical features 
of hypothyroidism including goitre, skin 
changes and fall of hair, over a period of 
1.5—2.5 years of therapy (Mean : 1.7 
years). They were treated with thyroid; 
lithium was continued without any fur-
ther impairment of thyroid function. 
Clinical features of hypothyroid state 
receded. 
Relation to Serum levels and 
dosage of lithium : All the side effects 
were experienced while the oral dose of 
lithium was 750-1000 me/day in 3 divided 
doses and the serum lithium levels well 
within the range of 0.6 — 1.2 mMol/litre. 
There was no correlation between these 
and any specific side effects. 
Relation to Clinical Response : 
Out of the 120 patients, 43, who were 
continuously on lithium for 4 years or 
more, were chosen for examining side 
effects reported by them in relation to 
their clinical response. They were 
divided into two groups—Group I & 
Group II. Group I maintained remission 
without any relapse and Group II suffer-
ed relapses during therapy. Table III 
shows the observations. 
TABLE III 
Group I Group II 
Total No. of patients: 13 30 
No. in whom side effects were 
observed: 10(77%) 22(70%) 
Neuromuscular (Tremor, 
Gait prcbkms) 8(80%) 13(59%) 
CNS (Memory defect, Tardive 
dyskinesia) 8(80%) 8(36.3%) 
G. I. (Nausea, loose bowels, 
excess salivation) 9(90%) 8(36.3%) 
Endocrine and Metabolic 
(Hypothyroidism, weight gain) 4(40%) 12(54.5%) 
Water balance (Polyuria) 8(80%) 12(54.5%) 
Of the 43 on long term therapy, 13 
were good responders (Group I) with no 
relapses; of these 10 (77%) had side 
effects. Of the 30 moderate responders 
(Group II), 22 (70%) had side effects. 
The difference in incidence between the 
groups was not statistically significant. 
In the Group I the incidence of G. I. 
problems, tremors and polyuria was signi-
ficantly higher than in the Group II. In 
the latter, however, endocrine and meta-
bolic effects were more frequent (54.5%) 
than in Group I (40%). 
DISCUSSION 
The gastrointestinal problems of nausea, 
looseness of bowel.-, and abdominal discom-
fort are said to occur in conjunction with 
the absorption of the ion and its rising 
blood concentrations. While mild hy-
permo'.ility of the intestines, nausea and 
changes in appetite can occur even with 
low serum levels, frank diarrhoea and 
vomiting indicate imminent toxicity and 
call for stopping lithium (NIMH report 90  VENKOBA RAO et al. 
1970; Schou, 1976). The hitter symptoms 
did not occur in the patients we studied. 
Tremors and polyuria were the most 
frequent symptoms in the patients, as in 
certain other reports. A significant re-
duction in these symptoms following dis-
continuation of lithium has been sugges-
ted as evidence that they are genuine side 
effects due to lithium (Christodoulott and 
Lykouras, 1982). In our study too, the 
severe tremors experienced by two patients 
disappeared on withdrawal of lithium 
confirming the trcmorigenic role of 
Lithium. Hand tremors during lithium 
therapy have a frequency different from 
Parkinsonian tremors and are believed to 
be non-extrapyramidal(Asnis et al., 1979). 
They are not relieved by anticholinergics 
but arc amenable to beta-blockers (Schou, 
1976). The present study confirmed 
this. Betablockers may be discontinued 
after reduction in tremors without recur-
rence of tremors in many. In intoxica-
tion, the fine tremors progress to coarse 
tremors and predispose to cogwheel 
rigidity (Schou et al., 1976; Asnisctal., 
1979). 
Tardive dyskinesia, noted in 4 cases 
of our series mitigated without any speci-
fic treatment. This is of interest in the 
context of reports that lithium might be 
of benefit in tardive dyskinesia (Reda 
et al., 1975). There are reports of extra-
pyramidal features during lithium therapy 
(Shopsin and GersJ-.on, 1975; Branchey 
et al., 1976 and Asnis et al., 1979), and 
also on aggravation of pre-existing tardive 
dyskinesia by lithium with near toxic 
levels (Crews et ah, 1977). 
Memory defects, observed earlier in 
our study (Sugum;T et al., 1980) and by 
others (Judd et al., 1979; Kusumo and 
Vaughan, 1977) arc not severe and tend 
to clear over time. Others report no 
significant memory problem:; during 
lithium therapy (Telford and \Vorrall, 
1978; Engelsmann, 1980; Singh etal., 
1982). 
Lithium induced hypothyroidism and 
goiter have been described by many in-
vestigators (Schou et al., 1976; Fieve and 
Platman, 1968, 1969). The reported 
incidence of hypothyroidism varies from 
6-30% (Lindstedt et al., 1977). In this 
study it is about 9% (N = 7) out of the 
78 patients who were on treatment for 
more than 1.5 years (the mean time of 
onset of hypothyroidism being 1.7 years 
of therapy in the present study), lower 
than the higher incidence (30%) reported 
by Fieve and Platman (1968,1969). In 
these studies, estimations of thyroid hor-
mones in blood have enabled detection of 
latent hypothyroidism also. Our study 
has been limited to clinically manifest 
case. The anti-thyroid effect of lithium 
is inherent in its anti manic effect. Li-
thium inhibits release of thyroxine and 
reduces the intra-thyroid indothyronine/ 
iodotyrosine ratio (Sedvall etal, 1968). 
Latent hypothyroidism is believed to set 
in early as a natural physiological sequel, 
corrected by the pituitary thyroid axis 
(NIMH report, 1970). An increase in 
TRH and TSH occurs secondarily and 
restores the balance; A few cases of 
transient thyrotoxicosis consequent on 
increase in TRH and TSH have been 
reported as evidence of an overadaptive 
response to lithium, induced hypothy-
roidism (Reus et a!., 1979; Brownlie et al., 
1976; Rosser, 1976). 
Weight gain has been reported to be 
a frequent effect of lithium treatment 
(Kerry etal., 1970; Grof et al., 1973; 
Vendsborg et al., 1976). In the present 
study, only 9 out of 120 (7.5%) have 
gained weight more than 3 kg between 3 
months to 1 year of treatment. Changes 
in lipid metabolism, increase in serum 
mrgnesium and calcium and changes in 
carbohydrate metabolism with increased 
glucose tolerance (Mellerup etal., 1973; 
Vendsborg, 1979) have been suggested to 
be associated with weight increase. A 
metabolic readjustment is presumed to A STUDY OF SIDE EFFECTS OF LITHIUM  91 
occur, since after an initial increase, the 
gain reaches a plateau and slowly returns 
to the prc-treatment weight levels. 
In the present study, there has been 
no occasion to study foetal anomalies due 
to lithium. The 42 females included un-
married girls, widows and divorced women 
who are not remarried, patients who have 
had tubectomy and post-menopausal 
women; others did not conceive during 
the period of lithium therapy. 
RELATION TO DOSE AND SERUM LEVELS: 
All the patients received regular 
preparations of lithium consuming the 
daily requirement in two or three divided 
doses. As such any spec fie advantage of 
single dose .schedule over the divided dose 
regimen can not be made out from this 
study. Mellerup et al. (1979) observed 
that tremor, polyuria and weight gain are 
seen both in patients taking single daily 
doses as well as in those taking two or 
three doses. Except in two of the patients 
the side effects in the present study were 
not severe enough to warrant discontinua-
tion of treatment. No specific relation 
has been detected between serum levels 
and side effects. In some reports tremor, 
nausea and abdominal discomfort were 
found to be related to the peak levels cf 
serum lithium (Persson, 1977) whereas 
this was not found by others (Edstrom & 
Persson, 1977; Fyro et al., 1970). 
RELATION TO CLINICAL RESPONSE 
Ananth et al. (1977) observe that there is 
a greater incidence of side effects in the 
responders and that they tended to ex-
perience more endocrine side effect.? than 
the non-respondcrs. Grof et al. (1973) 
report a positive association betwee.i 
weight gain and response to lithium. The 
findings of the present study on the other 
hand indicate a higher occurrence of 
neurological, gastrointestinal and renal 
side effects in the good responders and 
endocrine and metabolic effects (hypo-
thyroidism, weight gain) in the moderate 
responders. 
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